MIRA INFORM REPORT

Report Date :

16.05.2011

IDENTIFICATION DETAILS

Name :	BIO-LABS (PRIVATE) LIMITED

Registered Office :	Office # 1, 3^rd Floor, Rabi Centre, Murree Road, Rawalpindi

Country :	Pakistan

Year of Establishment :	1989

Com. Reg. No.:	0020824

Legal Form :	Private Limited Company

Line of Business :	Manufacture & Marketing of Pharmaceutical Products

RATING & COMMENTS

MIRA’s Rating :

RATING		STATUS	PROPOSED CREDIT LINE
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory

Status :	Satisfactory

Payment Behaviour :	No complaints

Litigation :	Clear

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – March 31^st, 2010

Country Name

Previous Rating

(31.12.2010)

Current Rating

(31.03.2011)

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

Business Name

BIO-LABS (PRIVATE) LIMITED

Full Address

Registered Address

Office # 1, 3^rd Floor, Rabi Centre, Murree Road, Rawalpindi, Pakistan

Tel #	92 (51) 4853032, 4844241
Fax #	92 (51) 4844241

Short Description Of Business

a.	Nature of Business	Manufacture & Marketing of Pharmaceutical Products
b.	Year Established	1989
c.	Registration #	0020824

Branches

(1) Office # 4-C, Chuburji Centre, Multan Road, Lahore, Pakistan.

(2) Office # 3, 2nd Floor, Abu Tarab Building, Aminpur Bazar, Faisalabad, Pakistan.

Factory Location

Plot # 145, Kahuta Industrial Triangle,
Kahuta Road, Islamabad,

Pakistan

Auditors

Muniff Ziauddin & Co.

(Chartered Accountants)

Office No. 3, 1^st Floor, Rajan Plaza, F-10 Markaz, Islamabad, Pakistan

Legal Status

Subject Company was established as a Private Limited Company in 1989

Authorized Capital	Rs. 15,000,000/-
Issued & Paid up Capital	Rs. 10,959,750/-

Details of Directors

Names

Nationality

Address

Occupation

Designation

Mr. Shaukat Hussain Chaudhry

Mr. Bilal Shaukat

Mr. Usman Shaukat

Mr. Rizwan Shaukat

Pakistani

Office # 1, 3^rd Floor, Rabi Centre, Murree Road, Rawalpindi

Business

Chief Executive

Director

Shareholders

Names of Shareholders

No. of Shares

Mrs. Akhtar Begum

Mrs. Alia Ishfaq

Mr. Bakhtiar Ahmad

Mr. Bilal Shaukat

Mr. Shaukat Hussain Chaudhry

Mrs. Fauzia Ishfaq

Mr. Ikhlaq Ahmad

Mr. Muhammad Sohail

Mr. Qazi Ibrar-Ul-Wahid

Mr. Rizwan Shaukat

Mrs. Shazia Ishfaq

Mr. Usman Shaukat

Mrs. Yameena Ishfaq

5,975

10,833

275,000

62,225

368,375

10,833

21,668

218,400

100,000

500

10,833

500

10,833

Associates

Subsidiary

None

Associated Companies

(1) Eastern Veterinary Services, Pakistan.

(2) Rub Associates, Pakistan.

Products

Manufacture & Marketing of Pharmaceutical Products including Anti Anemic, Anti Depressant, Anti Epileptic, Anti Histamine, Anti Malarial, Anti Rheumatic, Anti Ulcerant, Antibiotic, Cough Supressant etc

Number of Employees

100

Annual Production Volume

The capacity and production of the company’s plant is indeterminable as it is multi-product and involves varying processes of manufacture

Annual Sales Volume

Year	In Pak Rupees
2008 - 2009	120,000,000/- (Estimated)

Importing Countries

Import of Pharmaceutical Raw Materials from Europe, India & China

Distributors

Currently exist at all major cities of Pakistan

Exporting Countries

Mainly to Afghanistan & Kenya

Bankers

(1) Askari Bank Limited, Pakistan.

(2) Habib Bank Limited, Pakistan.

(3) Bank Alfalah Limited, Pakistan.

(4) United Bank Limited, Pakistan.

(5) Allied Bank Limited, Pakistan.

Memberships

· Pakistan Pharmaceutical Manufacturers Association.

· Rawalpindi Chamber of Commerce & Industry.

Foreign Exchange Rates

Currency	Unit	Pakistani Rupee
US Dollar	1	Rs. 85.80
UK Pound	1	Rs. 140.20
Euro	1	Rs. 123.30

Comments

Subject Company was established in 1989 and is engaged in manufacture & marketing of Pharmaceutical Products. Market reputation is satisfactory. Trade relations are reported as fair. Subject can be considered for normal business dealings at usual trade terms and conditions.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.44.68
UK Pound	1	Rs.73.04
Euro	1	Rs.64.29

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
--	NB	New Business	--

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.